Registered Phase-1b 12-week study investigating safety, diabetes control, and weight loss KELOWNA, BC / ACCESS Newswire / February 5, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "L ...

AI’s role in healthcare evolved significantly in 2024. Rather than generic AI solutions, startups focused on specialized, ...

Discontinuation of GLP-1 receptor agonists in obesity is common, driven by weight regain and socioeconomic factors, impacting ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

How will Feb. 1 tariffs affect you? U.S. figure skater Spencer Lane, 16, shared a photo from inside American Eagle Flight ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

Analysts say the adoption of GLP-1 drugs, the expansion of AI and the growth of multi-billion-dollar M&A deals chart an ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...

Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.

GLP-1 medications such as Ozempic and Wegovy have had a transformative effect for those struggling with weight loss. Many ...

Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight ...

PMGC Holdings Inc. (NASDAQ: ELAB) shares are trading higher Friday after the company announced that its subsidiary, ...